3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Ovarian Neoplasms
6
Advanced Solid Tumours
5
Squamous Cell Carcinoma of Head and Neck
4
Small Cell Lung Carcinoma
4
Uterine Cervical Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Glioblastoma
3
Fallopian Tube Neoplasms
3
Uterine Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Solid Tumors
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Advanced Malignant Solid Neoplasm
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Triple-negative Metastatic Breast Cancer
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Rhabdomyosarcoma
1
Interventions
Cisplatin
35
Radiotherapy
20
Magnetic Resonance Spectroscopy
19
Cetuximab
17
Specimen Handling
15
pembrolizumab
13
Carboplatin
13
Radiotherapy, Intensity-Modulated
12
Fluorouracil
12
Docetaxel
12
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Platinum
9
Paclitaxel
8
Surgical Procedures, Operative
7
Drug Therapy
6
Biopsy
6
Taxes
5
toripalimab
4
X-Rays
4
Standard of Care
4
Fluorodeoxyglucose F18
4
Celecoxib
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Nutritional Status
3
Laser Therapy
3
Interviews as Topic
3
Hydroxyurea
3
130-nm albumin-bound paclitaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Laryngeal Neoplasms
×
adavosertib
×
Clear all
NCT03028766
2024-09-19
WISTERIA
University of Birmingham
Phase 1
Completed
9 enrolled